Blood blisters can also occur in the mouth for a variety of reasons including side effects to certain medications, nutritional deficiencies, and mouth injuries. Treatment
There are several methods of healing blood blisters, including elevation of the wound combined with application of a cold pack, and application of padded dressings or splints. See also
Bleeding – Loss of blood escaping from the circulatory system
Blister – Small pocket of fluid within the upper layers of the skin
Bruise – Type of localized bleeding in tissues outside blood vessels
Cherry angioma – Small bright red dome-shaped bump on the skin


== References ==
The litigation was complicated since there was a lack of clarity in jurisdiction between state laws, where product liability is determined, and federal law, which determines how drugs are labelled, as well as between generics companies, which had no control over labelling, and the originator company, which did. The litigation yielded at least two important cases. In Conte v. Wyeth in the California state courts, the claims of the plaintiff against the generic companies Pliva, Teva, and Purepac that had sold the drugs that the plaintiff actually took, and the claims against Wyeth, whose product the plaintiff never took, were all dismissed by the trial court, but the case was appealed, and in 2008 the appellate court upheld the dismissal of the cases against the generic companies, but reversed on Wyeth, allowing the case against Wyeth to proceed. This established an "innovator liability" or "pioneer liability" for pharmaceutical companies. The precedent was not widely followed in California nor in other states. Litigation over the same issues related to metoclopramide also reached the US Supreme Court in PLIVA, Inc. v. Mensing, in which the court held in 2011 that generic companies cannot be held liable for information, or the lack of information, on the originators label.